Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France
Cardiology Department, University Hospital Centre Amiens-Picardie South Site, Amiens, France.
Heart. 2023 May 26;109(12):951-958. doi: 10.1136/heartjnl-2022-322167.
The TRI-SCORE reliably predicts in-hospital mortality after isolated tricuspid valve surgery (ITVS) on native valve but has not been tested in the setting of redo interventions. We aimed to evaluate the predictive value of the TRI-SCORE for in-hospital mortality in patients with redo ITVS and to compare its accuracy with conventional surgical risk scores.
Using a mandatory administrative database, we identified all consecutive adult patients who underwent a redo ITVS at 12 French tertiary centres between 2007 and 2017. Baseline characteristics and outcomes were collected from chart review and surgical scores were calculated.
We identified 70 patients who underwent a redo ITVS (54±15 years, 63% female). Prior intervention was a tricuspid valve repair in 51% and a replacement in 49%, and was combined with another surgery in 41%. A tricuspid valve replacement was performed in all patients for the redo surgery. Overall, in-hospital mortality and major postoperative complication rates were 10% and 34%, respectively. The TRI-SCORE was the only surgical risk score associated with in-hospital mortality (p=0.005). The area under the receiver operating characteristic curve for the TRI-SCORE was 0.83, much higher than for the logistic EuroSCORE (0.58) or EuroSCORE II (0.61). The TRI-SCORE was also associated with major postoperative complication rates and survival free of readmissions for heart failure.
Redo ITVS was rarely performed and was associated with an overall high in-hospital mortality and morbidity, but hiding important individual disparities. The TRI-SCORE accurately predicted in-hospital mortality after redo ITVS and may guide clinical decision-making process (www.tri-score.com).
TRI-SCORE 可可靠地预测原发性三尖瓣手术(ITVS)后孤立性三尖瓣手术的住院死亡率,但尚未在 redo 干预的情况下进行测试。我们旨在评估 TRI-SCORE 在 redo ITVS 患者中预测住院死亡率的价值,并比较其与传统手术风险评分的准确性。
我们使用强制性行政数据库,确定了 2007 年至 2017 年间在 12 个法国三级中心接受 redo ITVS 的所有连续成年患者。从病历回顾中收集基线特征和结果,并计算手术评分。
我们确定了 70 例接受 redo ITVS 的患者(54±15 岁,63%为女性)。先前的干预措施在 51%的患者中为三尖瓣修复,在 49%的患者中为三尖瓣置换,在 41%的患者中与另一手术联合进行。所有患者均对 redo 手术进行了三尖瓣置换。总体而言,住院死亡率和主要术后并发症发生率分别为 10%和 34%。TRI-SCORE 是唯一与住院死亡率相关的手术风险评分(p=0.005)。TRI-SCORE 的受试者工作特征曲线下面积为 0.83,远高于逻辑 EuroSCORE(0.58)或 EuroSCORE II(0.61)。TRI-SCORE 还与 major postoperative complication rates 和心力衰竭再入院的生存率相关。
redo ITVS 很少进行,且与整体较高的住院死亡率和发病率相关,但掩盖了重要的个体差异。TRI-SCORE 可准确预测 redo ITVS 后的住院死亡率,并可能指导临床决策过程(www.tri-score.com)。